Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Gen Virol ; 84(Pt 5): 1253-1259, 2003 May.
Artículo en Inglés | MEDLINE | ID: mdl-12692291

RESUMEN

It was demonstrated using self-replicating hepatitis C virus (HCV) RNAs that both types of interferons (IFNs) (in particular IFN-alpha and IFN-gamma) are potent inhibitors of HCV replication in Huh-7 cells. Because IFN-gamma and tumour necrosis factor (TNF)-alpha trigger a partially overlapping set of antiviral defence mechanisms, it is tempting to speculate that TNF-alpha also inhibits HCV replication. However, this study shows that TNF-alpha does not affect HCV protein and RNA synthesis, nor does it synergistically enhance the inhibitory effect of IFN-gamma. Taken together, these results demonstrate that HCV replication in Huh-7 cells is highly resistant to TNF-alpha. It is, therefore, unlikely that the increased production of TNF-alpha, which is seen in many hepatitis C patients, contributes to HCV clearance by inducing antiviral defence mechanisms in infected hepatocytes.


Asunto(s)
Hepacivirus/patogenicidad , ARN Viral/biosíntesis , Factor de Necrosis Tumoral alfa/farmacología , Replicación Viral/efectos de los fármacos , Antivirales/farmacología , Farmacorresistencia Viral , Hepacivirus/genética , Hepacivirus/fisiología , Humanos , Interferón gamma/farmacología , Células Tumorales Cultivadas
2.
Hepatology ; 35(3): 694-703, 2002 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-11870386

RESUMEN

Persistent infection with hepatitis C virus (HCV) is a major cause of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. All treatments known so far rely on the antiviral activity of interferon alfa (IFN-alpha) that is given alone or in combination with ribavirin. Unfortunately, only a fraction of the patients clear the virus during therapy and for those who do not respond there is currently no alternative treatment. Selectable subgenomic HCV RNAs (replicons) have been recently used to investigate the effect of IFN-alpha on HCV replication. However, it has not yet been analyzed whether other cytokines also play a role in the innate immune response against HCV. Here we show that IFN-gamma inhibits protein synthesis and RNA replication of subgenomic and genomic HCV replicons. We further show that the inhibitory action of IFN-gamma does not rely on the production of nitric oxide or the depletion of tryptophan. In conclusion, our results suggest that cytotoxic T cells and natural killer cells may contribute to HCV clearance not only by cell killing but also by producing IFN-gamma, thereby enhancing the intracellular inhibition of viral replication.


Asunto(s)
Hepacivirus/efectos de los fármacos , Interferón gamma/farmacología , ARN Viral/biosíntesis , Replicación Viral/efectos de los fármacos , Hepacivirus/genética , Humanos , Interferón Tipo I/biosíntesis , Óxido Nítrico/biosíntesis , Óxido Nítrico Sintasa/fisiología , Óxido Nítrico Sintasa de Tipo II , Replicón/efectos de los fármacos , Triptófano/metabolismo , Células Tumorales Cultivadas , Proteínas no Estructurales Virales/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA